January 7, 2016 — Scientists have found that women who suffer unexplained heart failure towards the end of pregnancy or shortly after giving birth share certain genetic changes.

Corindus Vascular Robotics Inc. announced the launch of a CorPath robotic-assisted coronary intervention program at Massachusetts General Hospital (MGH) and the installation of its first CorPath System.


Clinical decision support (CDS) software has been discussed for years as a way to help clinicians follow best practice guidelines and help eliminate unnecessary tests or procedures. However, implementing these systems has been slow, partly due to their cost and complexity and pushback from physicians. But, a new chapter is about to open for CDS as healthcare reform will soon require implementation of these systems.

A new study determined that the Watchman left atrial appendage closure device is more cost-effective than warfarin and non-warfarin oral anticoagulants (NOACs) for stroke reductions in non-valvular atrial fibrillation patients.

The Medicines Company announced Dec. 18 it has entered into a purchase agreement pursuant to which certain subsidiaries of Mallinckrodt plc will acquire The Medicines Company’s global portfolio of hemostasis products.

A new study from the Healthcare Information and Management Systems Society (HIMSS) offers insight from nearly 200 healthcare executives (C-Suite, administrators, directors and vice presidents) on their population health initiatives, and their current and future approach to population health IT solutions and consultants.

Johns Hopkins has demonstrated in animals that applying a pacemaker’s mild electrical shocks to push the heart in and out of normal synchronized contraction for part of each day may be an effective way to slow down the progression of heart failure.

Booz Allen Hamilton  and Kaggle announced that the second annual Data Science Bowl will call on the global data science community to create a set of steps, or algorithms, to help transform diagnosis of heart disease. Through a partnership with the National Institutes of Health (NIH), participants in the 90-day competition will be given magnetic resonance imaging (MRI) images and asked to develop an algorithm to automate the measurements that are key indicators of heart disease.

January 4, 2016 — In a comparison of bleeding complications and mortality between transradial and transfemoral stent placement following a heart attack, researchers from the Perelman School of Medicine at the University of Pennsylvania found those at risk for more bleeding were often treated with the riskier transfemoral approach. – a demonstration of the so-called risk-treatment paradox. The findings, from the largest study of its kind, were detailed in the Dec.

January 4, 2016 — Living with pulmonary arterial hypertension (PH) is challenging, but the chore of treating the rare heart disease may change following promising clinical trial data published in the Dec. 24 issue of the New England Journal of Medicine.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now